Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,619,800 | 1,844,300 | 1,391,900 | 1,326,070 | 1,189,880 |
| Marketable Securities | 580,000 | 1,030,000 | 1,050,000 | 720,000 | 480,000 |
| Receivables | 880,900 | 836,300 | 830,700 | 764,364 | 714,004 |
| Inventories | 443,000 | 437,500 | 417,000 | 483,111 | 504,989 |
| Other current assets | 244,500 | 285,300 | 323,900 | 315,441 | 297,560 |
| TOTAL | $3,968,200 | $4,583,100 | $4,166,000 | $3,755,878 | $3,350,433 |
| Non-Current Assets | |||||
| PPE Net | 212,000 | 203,100 | 199,900 | 188,913 | 184,975 |
| Intangibles | 5,829,300 | 6,008,800 | 6,258,800 | 6,393,220 | 6,612,961 |
| Other Non-Current Assets | 1,071,400 | 1,064,600 | 1,034,600 | 1,018,474 | 795,772 |
| TOTAL | $7,112,700 | $7,276,500 | $7,493,300 | $7,600,607 | $7,593,708 |
| Total Assets | $11,080,900 | $11,859,600 | $11,659,300 | $11,356,490 | $10,944,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,016,400 | 1,030,500 | 1,029,900 | 1,029,179 | 1,028,478 |
| Accounts payable and accrued liabilities | 128,500 | 100,000 | 122,100 | 152,227 | 89,366 |
| Accrued Expenses | 1,030,000 | 1,022,400 | 1,034,200 | 1,001,556 | 874,811 |
| TOTAL | $2,230,800 | $2,246,600 | $2,242,500 | $2,274,102 | $2,071,205 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,335,000 | 4,324,200 | 4,328,400 | 4,331,982 | 4,335,616 |
| Other Non-Current Liabilities | 184,500 | 208,800 | 175,300 | 162,338 | 148,838 |
| TOTAL | $4,048,400 | $5,080,700 | $5,098,200 | $5,123,353 | $5,166,577 |
| Total Liabilities | $6,279,200 | $7,327,300 | $7,340,700 | $7,397,455 | $7,237,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,915 | 62,743 | 61,560 | 60,765 | 60,659 |
| Common Shares | 100 | 100 | 100 | 61 | 61 |
| Retained earnings | 1,132,500 | 939,700 | 646,600 | 443,198 | 191,786 |
| Other shareholders' equity | -662,500 | -651,000 | -568,600 | -569,898 | -485,768 |
| TOTAL | $4,801,700 | $4,532,300 | $4,318,600 | $3,959,030 | $3,706,359 |
| Total Liabilities And Equity | $11,080,900 | $11,859,600 | $11,659,300 | $11,356,485 | $10,944,140 |